A small study of 8 healthy older adults found that GHRH administration before sleep increased slow-wave sleep duration by 25% and decreased REM sleep latency (Steiger et al., Neuroendocrinology 1992)
The Takeaway While both Novo and Lilly have multi-year regulatory head-starts and are now rapidly becoming part of the zeitgeist around treating obesity, Regenerons angle of addressing muscle loss could help set it apart from other GLP-1 hopefuls and even incumbents by leading to improved long-term outcomes.
Hoens for her feedback on an early version of this table
In this work, anti-EF monoclonal antibodies (MAb) were produced following immunization of mice, and four of the
Not all positive reviews are genuine, and not all negative reviews are fair
She continues to consume 150 grams of protein daily, walks about 15,000 steps most days and strength trains three times per week